PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Achieve Life Sciences, Inc. (ACHV)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS0044685008
CUSIP004468500
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$168.62M
EPS (TTM)-$1.26
Gross Profit (TTM)-$214.00K
EBITDA (TTM)-$16.83M
Year Range$3.03 - $5.98
Target Price$18.00
Short %5.78%
Short Ratio3.71

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Achieve Life Sciences, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Achieve Life Sciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%200.00%400.00%600.00%800.00%FebruaryMarchAprilMayJuneJuly
-100.00%
830.74%
ACHV (Achieve Life Sciences, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Achieve Life Sciences, Inc. had a return of 19.17% year-to-date (YTD) and -8.57% in the last 12 months. Over the past 10 years, Achieve Life Sciences, Inc. had an annualized return of -51.65%, while the S&P 500 had an annualized return of 10.64%, indicating that Achieve Life Sciences, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date19.17%13.78%
1 month3.81%-0.38%
6 months7.91%11.47%
1 year-8.57%18.82%
5 years (annualized)-33.32%12.44%
10 years (annualized)-51.65%10.64%

Monthly Returns

The table below presents the monthly returns of ACHV, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202419.66%-17.85%12.22%-3.41%18.91%-9.96%19.17%
202398.37%-0.21%40.21%22.50%-25.57%-16.29%7.90%-11.43%-13.31%-6.51%44.03%-28.84%68.16%
2022-6.17%1.37%2.30%-8.45%-0.43%-29.28%3.48%-9.70%-27.63%-33.03%26.70%-12.50%-68.51%
202150.62%-6.39%1.40%-6.82%-25.76%12.11%-18.60%14.23%1.80%-2.47%-13.15%8.06%-3.95%
20205.96%-14.51%-31.90%29.03%-3.20%-2.77%71.66%-40.06%2.45%-6.09%9.67%-6.03%-23.57%
201923.97%63.33%31.84%31.58%-0.94%-54.16%-5.18%8.74%-14.57%-24.12%-28.72%-42.37%-56.21%
201817.62%-18.99%-0.78%7.09%-35.81%-56.70%-13.23%-8.23%4.65%-35.24%-25.49%-20.39%-90.99%
201712.02%-2.68%-18.90%-13.55%-0.52%-5.37%18.15%-24.92%-42.17%-14.78%-23.12%1.00%-75.57%
2016-45.45%-9.09%13.92%42.65%2.56%0.00%-11.00%-39.33%-6.11%-17.16%9.76%8.44%-58.69%
2015-12.23%14.18%-6.32%-6.51%5.47%9.91%48.07%-15.65%-23.37%-7.17%24.64%-53.10%-47.16%
201429.50%2.04%6.72%-67.01%-2.32%-1.58%-19.03%9.60%-19.34%-16.10%-5.80%8.53%-72.54%
20130.30%-9.65%-4.71%-10.59%1.68%-4.85%-0.31%-8.39%3.58%-24.16%22.19%-2.91%-36.43%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ACHV is 44, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of ACHV is 4444
ACHV (Achieve Life Sciences, Inc.)
The Sharpe Ratio Rank of ACHV is 4242Sharpe Ratio Rank
The Sortino Ratio Rank of ACHV is 4545Sortino Ratio Rank
The Omega Ratio Rank of ACHV is 4747Omega Ratio Rank
The Calmar Ratio Rank of ACHV is 4343Calmar Ratio Rank
The Martin Ratio Rank of ACHV is 4141Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Achieve Life Sciences, Inc. (ACHV) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ACHV
Sharpe ratio
The chart of Sharpe ratio for ACHV, currently valued at -0.10, compared to the broader market-2.00-1.000.001.002.003.00-0.10
Sortino ratio
The chart of Sortino ratio for ACHV, currently valued at 0.36, compared to the broader market-4.00-2.000.002.004.000.36
Omega ratio
The chart of Omega ratio for ACHV, currently valued at 1.06, compared to the broader market0.501.001.502.001.06
Calmar ratio
The chart of Calmar ratio for ACHV, currently valued at -0.07, compared to the broader market0.001.002.003.004.005.00-0.07
Martin ratio
The chart of Martin ratio for ACHV, currently valued at -0.30, compared to the broader market-30.00-20.00-10.000.0010.0020.00-0.30
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.66, compared to the broader market-2.00-1.000.001.002.003.001.66
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.33, compared to the broader market-4.00-2.000.002.004.002.33
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.29, compared to the broader market0.501.001.502.001.29
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.35, compared to the broader market0.001.002.003.004.005.001.35
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 6.32, compared to the broader market-30.00-20.00-10.000.0010.0020.006.32

Sharpe Ratio

The current Achieve Life Sciences, Inc. Sharpe ratio is -0.10. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Achieve Life Sciences, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00FebruaryMarchAprilMayJuneJuly
-0.10
1.66
ACHV (Achieve Life Sciences, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Achieve Life Sciences, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%FebruaryMarchAprilMayJuneJuly
-100.00%
-4.24%
ACHV (Achieve Life Sciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Achieve Life Sciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Achieve Life Sciences, Inc. was 100.00%, occurring on Nov 4, 2022. The portfolio has not yet recovered.

The current Achieve Life Sciences, Inc. drawdown is 100.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Mar 4, 19986211Nov 4, 2022
-30.11%Jun 12, 199637Aug 2, 199664Nov 4, 1996101
-22.41%Jan 18, 199619Feb 13, 19967Feb 23, 199626
-19.74%Mar 25, 199634May 10, 19963May 15, 199637
-14%Jan 3, 19966Jan 10, 19961Jan 11, 19967

Volatility

Volatility Chart

The current Achieve Life Sciences, Inc. volatility is 12.66%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%FebruaryMarchAprilMayJuneJuly
12.66%
3.80%
ACHV (Achieve Life Sciences, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Achieve Life Sciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

P/E Ratio

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Achieve Life Sciences, Inc..


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items